AMS Scale Effectiveness in Measuring Quality of Life in Androgen-Deficient Males
Author Information
Author(s): Heinemann Lothar A, Moore Claudia, Dinger Juergen C, Stoehr Diana
Primary Institution: Center for Epidemiology & Health Research Berlin
Hypothesis
The AMS scale can effectively measure treatment effects on quality of life in androgen-deficient males.
Conclusion
The AMS scale effectively measures treatment effects on quality of life across various severity levels of complaints.
Supporting Evidence
- The AMS scale showed a 30.7% improvement in total score after treatment.
- Patients with severe symptoms showed a 39% improvement compared to baseline.
- The AMS scale can predict the physician's opinion on treatment success with over 70% sensitivity and specificity.
- Age, BMI, and testosterone levels did not significantly affect treatment outcomes.
Takeaway
The AMS scale helps doctors see how well testosterone treatment is working for men with low testosterone, showing improvements in their quality of life.
Methodology
An open post-marketing study was conducted with 1670 androgen-deficient males treated with testosterone gel, using the AMS scale before and after 12 weeks of treatment.
Potential Biases
The study may have bias due to the lack of randomization and potential conflicts of interest from authors affiliated with testosterone product companies.
Limitations
The study did not determine a required sample size and was observational in nature.
Participant Demographics
{"mean_age":56.4,"mean_BMI":26.8,"testosterone_level":2.5}
Statistical Information
P-Value
<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website